Hyperferritinemia and Hypergammaglobulinemia Predict the Treatment Response to Standard Therapy in Autoimmune Hepatitis

PLoS ONE - United States
doi 10.1371/journal.pone.0179074
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Can Gender Predict Virological Response to Standard Antiviral Therapy for Chronic Hepatitis C? A Retrospective Study

Hepatoma Research
2016English

Methotrexate in the Treatment of Autoimmune Hepatitis

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2018English

Serum Levels of IL-33 and Correlation With IL-4, IL-17A, and Hypergammaglobulinemia in Patients With Autoimmune Hepatitis

Mediators of Inflammation
ImmunologyCell Biology
2018English

Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4

PLoS ONE
Multidisciplinary
2015English

Enrichment of Genetic Variants in the Glucocorticoid Receptor Signalling Pathway in Autoimmune Hepatitis With Failure of Standard Treatment

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan

PLoS ONE
Multidisciplinary
2013English

Letter: Vitamin D Deficiency and Autoimmune Hepatitis - From Research to Treatment

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Clinical Picture, Diagnostics and Treatment of Autoimmune Hepatitis

Doctor.Ru
2019English

Impairments in Goal-Directed Actions Predict Treatment Response to Cognitive-Behavioral Therapy in Social Anxiety Disorder

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy